PHENOBARBITAL MARKET ANALYSIS

Name: Phenobarbital Market News
Creator: Coherent Market Insights
License: https://www.coherentmarketinsights.com/privacy-policy

Phenobarbital Market, By Indication (Epilepsy and Neonatal Seizures), By Dosage Form (Tablets, Capsules, and Injectables), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Recent Developments

New product launches

On January 25 2023, Sun Pharmaceutical Industries Ltd., a multinational pharmaceutical company, launched the SEZABY (phenobarbital sodium) in the U.S. for the treatment of neonatal seizures.

Agreements

In November 2022, Sun Pharmaceutical Industries Ltd., a multinational pharmaceutical company, and Sun Pharma Advanced Research Company Ltd. (SPARC), a clinical stage bio-pharmaceutical company, announced the signing of a licensing agreement for commercialization of benzyl alcohol and propylene glycol-free phenobarbital sodium powder for injection in the U.S.